GlassScriptPhysician profile
Natalie King
NPI 1396122735
$9,710.44
in general payments reported to CMS, 2019-2025
47 companies · $1,646 in 2025
The $1,646 reported for 2025 was more than what 91% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,422 · 2022: $2,399 · 2023: $1,543 · 2024: $1,700 · 2025: $1,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,829 · Education: $60.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,828.53 |
| Education | $60.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,392.52 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $978.02 | 2021-2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $889.09 | 2021-2024 | Farxiga |
| Lilly USA, LLC | $564.12 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Mannkind Corporation | $462.89 | 2021-2023 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $450.65 | 2021-2025 | Jardiance |
| Amgen INC. | $447.01 | 2021-2025 | Evenity, Prolia, Prolia |
| Xeris Pharmaceuticals, INC. | $359.90 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Bayer Healthcare Pharmaceuticals INC. | $352.95 | 2022-2025 | |
| Tandem Diabetes Care, INC. | $319.99 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Acadia Pharmaceuticals INC | $300.00 | 2022 | |
| Insulet Corporation | $287.93 | 2021-2024 | Omnipod |
| Abbott Laboratories | $272.92 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amarin Pharma, INC. | $267.10 | 2021 | |
| Dexcom, INC. | $249.39 | 2021-2025 | Dexcom G6 Transmitter |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $238.35 | 2023-2025 | Cequr Simplicity |
| Sanofi-Aventis U.S. LLC | $207.91 | 2021-2025 | |
| Zealand Pharma US, INC. | $171.31 | 2021 | |
| Sequel Med Tech, LLC | $155.88 | 2025 | Twiist |
| Merck Sharp & Dohme LLC | $152.88 | 2021-2023 | Steglatro, Steglujan |
| Medtronic, INC. | $106.02 | 2021-2025 | Minimed 780g |
| Ibsa Pharma INC. | $96.21 | 2021-2023 | Tirosint, Licart |
| Horizon Therapeutics Plc | $85.38 | 2021 | |
| Abbvie INC. | $82.60 | 2021-2023 | |
| Lifescan, INC. | $78.70 | 2021-2022 | |
| Intuity Medical INC | $76.26 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Radius Health, INC. | $68.33 | 2021-2025 | Tymlos |
| Recordati_rare_diseases_inc. | $67.06 | 2022-2025 | Isturisa |
| Beta Bionics, INC. | $59.51 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Alexion Pharmaceuticals, INC. | $57.67 | 2021-2022 | |
| Esperion Therapeutics, INC. | $54.20 | 2021-2022 | |
| Pfizer INC. | $45.64 | 2021-2022 | |
| Ascensia Diabetes Care US INC. | $37.18 | 2021-2023 | |
| Acerus Pharmaceuticals Corporation | $28.08 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $25.25 | 2022 | |
| Currax Pharmaceuticals LLC | $25.02 | 2021 | |
| Rgh Enterprises LLC | $22.57 | 2025 | |
| Clarus Therapeutics INC. | $20.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.33 | 2024 | |
| Eusa Pharma (US) LLC | $19.92 | 2022 | |
| Antares Pharma, INC. | $19.65 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $19.07 | 2024 | |
| Neurocrine Biosciences, INC. | $16.66 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $16.46 | 2023 | Evkeeza |
| Evoke Pharma, INC. | $15.88 | 2025 | |
| Renalytix Ai, INC. | $14.44 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.